MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Automatic Estimation of MDS-UPDRS Gait Scores from Videos with Multi-Rater Disagreements

    E. Adeli, E. Sullivan, M. Lu, Q. Zhao, L. Montaser Kouhsari, M. Katz, A. Pfefferbaum, K. Pohl, V. Henderson, K. Poston (Stanford, USA)

    Objective: Early diagnosis of Parkinson's disease (PD) and tracking its signs are crucial for developing treatment plans. The MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) defines…
  • MDS Virtual Congress 2021

    Using Machine Learning to Predict the Best Outcomes with Electrical Muscle Stimulation for Tremors in Parkinson’s Disease

    O. Phokaewvarangkul, P. Vateekul, I. Wichakam, C. Anan, R. Bhidayasiri (Bangkok, Thailand)

    Objective: This study explores the effect of electrical muscle stimulation (EMS) on resting tremor and aims to identify the best machine learning model to predict…
  • MDS Virtual Congress 2021

    MR guided high-intensity ultrasound thalamotomy in essential tremor and Parkinson´s disease: is there an ideal candidate?

    I. Aviles-Olmos, A. Martín-Bastida, A. Gorospe-Osinalde, J. Carte-García, P. Manrique, A. Arcadi, O. Parras, M. Fernández-Martínez, L. Armengou-García, L. González-Quarante, J. Guridi, MC. Rodríguez-Oroz (Pamplona, Spain)

    Objective: To report the efficacy and safety of unilateral thalamotomy at Ventralis intermediate nucleus (VIM) by MR guided High-Intensity Focused Ultrasound (MRgHIFU) in treatment of…
  • MDS Virtual Congress 2021

    Synchronous or asynchronous exercises is beneficial compared to no exercise in Brazilian people with Parkinson’s disease during COVID-19 pandemic.

    E. Tardelli, E. Okamoto, F. Tarallo, K. Tanaka, F. Santinelli, L. Simieli, E. Costa, F. Barbieri (São Paulo, Brazil)

    Objective: To compare the self-reported motor and non-motor symptoms in Brazilian people with Parkinson´s disease (PD) that performed home-based remotely exercise (asynchronous or synchronous) or…
  • MDS Virtual Congress 2021

    Optimizing an Electronic Health Records (EHR)-based Algorithm for Parkinson’s Disease Case Ascertainment

    A. Duarte Folle, L. Uhr, F. Agosta, T. Chang, C. Baddley, B. Ritz, C. Tanner, A. Wu, A. Wilson (Los Angeles, USA)

    Objective: To develop an EHR-based algorithm to classify patients with PD into three levels of diagnostic certainty. Background: EHRs can be a rich source of…
  • MDS Virtual Congress 2021

    Model Innovation in Parkinson’s disease drug development: linking Quantitative Systems Pharmacology to the patient voice

    J. Barrett, B. Piccoli, M. Muller, K. Barrett, D. Goncharov, C. Kaddi, K. Azer, K. Romero, D. Stephenson (Tucson, USA)

    Objective: There is a growing sense of urgency to integrate the voice of the patient in drug development in Parkinson’s disease (PD). Public private partnerships…
  • MDS Virtual Congress 2021

    Direct Costs of patients with Parkinson’s Disease in a region of the Brazilian Amazon

    R. Feio, T. França, A. Passos, A. Silva, A. Escudeiro, B. Koshimoto, D. Moura, B. Lobato (Belém, Brazil)

    Objective: To evaluate the perception of the annual direct costs (medications, medical appointments, rehabilitation, transportation) associated with the treatment for patients with PD in the…
  • MDS Virtual Congress 2021

    Trunk postural control in seated position on a prototype of unstable chair and the interference of cognitive and motor tasks in individuals with Parkinson disease

    H. Araújo, A. Miri, R. Volpe, M. Oliveira, R. Silva Jr, S. Smaili (Londrina, Brazil)

    Objective: To analyze trunk balance control of individuals with Parkinson disease (PD) in seated position and compare the control position with motor and cognitive tasks.…
  • MDS Virtual Congress 2021

    The EPSILON (Early ParkinSon wIth L-dopa/DDCi and OpicapoNe) study in early Parkinson’s disease: design and rationale of a phase III, double-blind, randomized, placebo-controlled study

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

    Objective: This study aims to explore the potential of opicapone (OPC) to enhance the clinical benefit of levodopa (L-dopa)/dopa decarboxylase inhibitor (DDCi) in patients with…
  • MDS Virtual Congress 2021

    CVT-301 (levodopa inhalation powder): meta-analysis of safety in patients with Parkinson’s disease (PD)

    P. Lewitt, P. Zhao, A. Corbin, D. Kegler-Ebo, B. Blank (West Bloomfield, USA)

    Objective: Safety results from a phase 3, double-blind study of CVT-301 in patients with PD were combined with results from a 4-week, phase 2b, double-blind,…
  • « Previous Page
  • 1
  • …
  • 535
  • 536
  • 537
  • 538
  • 539
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley